Noteworthy

Jan 12, 2018
Pharmaceutical Executive
Bruno Strigini, CEO of Novartis Oncology, talks about the company’s pioneering path in cancer and the related broader issues such as pricing and value and new innovations in cancer science.
Jan 11, 2018
mHealth devices and apps that continuously monitor patient symptoms and help with adherence also are likely to reshape medical practice – and with it the products pharma produce, writes Vicki Anastasi.
Jan 11, 2018
Using intelligent automation of content creation can turn master product data into business value, writes Siniša Belina.
Jan 11, 2018
Pharmaceutical Executive
States will continue to press for price controls, while FDA will tackle opioids and promote innovation.
Jan 09, 2018
Pharmaceutical Executive
Five predictions on evolution of data and predictive insights that could be critical for pharma go-to-market strategies.
Jan 02, 2018
For the pharma sector across Europe, Brexit is just one of the tough issues to think about in 2018, writes Reflector.
Dec 31, 2017
Enacting landmark tax reform legislation that makes major changes in the corporate tax structure was Congress's Christmas present to President Trump — and to industry, writes Jill Wechsler.
Dec 30, 2017
Pharmaceutical Executive
Pharm Exec details the latest approaches to combating disease and health crises on a global scale—including industry perspectives from those involved on the front lines.
Dec 29, 2017
Pharmaceutical Executive
Amid a widening net of health threats worldwide, alliances forged in research and response may be more critical than ever to stem the tide.
Dec 22, 2017
Kilian Weiss talks to Pharm Exec about the modern challenges of identifying KOLs in oncology, and why technology can offer a solution to this vital process.
native1_300x100
levitra 20mg

Станозолол купить

читайте здесь
lorem ipsum